dimethyl fumarate

The drug is intended for the treatment of adult patients with relapsing-remitting forms of multiple sclerosis, including clinically isolated syndrome and active secondary progressive disease.

Form: capsules, modified release

ATC: L04AX07

Manufacturer: Amneal Pharmaceuticals Private Limited

The drug is intended for the treatment of adult patients with relapsing-remitting forms of multiple sclerosis, including clinically isolated syndrome and active secondary progressive disease.

Form: capsules, modified release

ATC: L04AX07

Manufacturer: Shilpa Medicare Limited (full production cycle; quality control and stability testing (physical and chemical tests))

Dimethylfumarate is indicated for the treatment of adult patients with relapsing-remitting forms of multiple sclerosis, including clinically isolated syndrome and active secondary progressive disease.

Form: capsules, modified release

ATC: L04AX07

Manufacturer: Shilpa Medicare Limited (full production cycle; quality control and stability testing (physical and chemical tests))

The drug is intended for the treatment of adults and children aged 12 years and older with relapsing-remitting multiple sclerosis.

Form: capsules, hard gastro-resistant

ATC: L04AX07

Manufacturer: JSC "Farmak" (secondary packaging, labeling, quality control, batch release from bulk products of manufacturer Sanovel Ilac Sanayi ve Ticaret A.S., Turkey (manufacturing, packaging, quality control and batch release))

The drug is indicated for the treatment of adults and children aged 12 years and older with relapsing-remitting multiple sclerosis.

Form: capsules, hard gastro-resistant

ATC: L04AX07

Manufacturer: JSC "Farmak" (secondary packaging, labeling, quality control, batch release from bulk products of manufacturer Sanovel Ilac Sanayi ve Ticaret A.S., Turkey (manufacturing, packaging, quality control and batch release))

The drug is intended for the treatment of adult patients with relapsing-remitting multiple sclerosis.

Form: capsules, hard gastro-resistant

ATC: L04AX07

Manufacturer: Teva Pharmaceutical Industries Ltd.

The drug is intended for the treatment of adult patients with relapsing-remitting multiple sclerosis.

Form: capsules, hard gastro-resistant

ATC: L04AX07

Manufacturer: Teva Pharmaceutical Industries Ltd.

The drug is intended for the treatment of adults and children aged 13 years and older with relapsing-remitting multiple sclerosis.

Form: capsules, modified release

ATC: L04AX07

Manufacturer: Sinten Chile Ltda. (Manufacturing of finished dosage form, primary and secondary packaging, batch control, batch release)

The drug is intended for the treatment of adults and children aged 12 years and older suffering from relapsing-remitting multiple sclerosis.

Form: capsules, modified release

ATC: L04AX07

Manufacturer: Sinten Chile Ltda. (Manufacturing of finished dosage form, primary and secondary packaging, batch control, batch release)

The drug is indicated for the treatment of adult patients with relapsing-remitting multiple sclerosis.

Form: capsules, modified release

ATC: L04AX07

Manufacturer: Hetero Labs Limited

The drug is indicated for the treatment of adult patients with relapsing-remitting multiple sclerosis.

Form: capsules, modified release

ATC: L04AX07

Manufacturer: Hetero Labs Limited

The drug is indicated for the treatment of adults and children aged 13 years and older with relapsing-remitting multiple sclerosis.

Form: capsules, hard gastro-resistant

ATC: L04AX07

Manufacturer: Sanovel Ilac Sanayi ve Ticaret, A.S. (manufacturing of finished dosage form, primary and secondary packaging, batch control)

The drug is indicated for the treatment of adults and children aged 13 years and older with relapsing-remitting multiple sclerosis.

Form: capsules, hard gastro-resistant

ATC: L04AX07

Manufacturer: Sanovel Ilac Sanayi ve Ticaret, A.S. (manufacturing of finished dosage form, primary and secondary packaging, batch control)